Frontiers in Immunology | Cancer Immunity and Immunotherapy

Review

Published on 12 Feb 2024

Achilles’ Heel of currently approved immune checkpoint inhibitors: immune related adverse events

in Cancer Immunity and Immunotherapy

Ting Yan
Lun Yu
Jiwen Zhang
Yun Chen
Yilan Fu
Jingyi Tang
Dehua Liao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1292122

6,915 views
19 citations

Systematic Review

Published on 12 Feb 2024

Pan-immune inflammation value as a prognostic biomarker for cancer patients treated with immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Tianrui Kuang
Zhendong Qiu
Kunpeng Wang
Lilong Zhang
Keshuai Dong
Weixing Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1326083

4,737 views
26 citations

Original Research

Published on 09 Feb 2024

Peripheral blood lymphocyte subsets predict the efficacy of TACE with or without PD-1 inhibitors in patients with hepatocellular carcinoma: a prospective clinical study

in Cancer Immunity and Immunotherapy

Hongyu Wang
Huijie Huang
Ting Liu
Yaoming Chen
Jinwei Li
Min He
Jianxin Peng
Enyu Liang
Jiaping Li
Wendao Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1325330

3,289 views
1 citation

Original Research

Published on 09 Feb 2024

An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer

in Cancer Immunity and Immunotherapy

Yongjia Cui
Weixuan Zhang
Wenping Lu
Yaogong Feng
Xiaoqing Wu
Zhili Zhuo
Dongni Zhang
Yichi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1228235

5,516 views
17 citations

Brief Research Report

Published on 09 Feb 2024

Germline defects of familial hemophagocytic lymphohistiocytosis-related genes presenting as adult-onset peripheral T-cell lymphoma

in Cancer Immunity and Immunotherapy

Chong Wei
Danqing Zhao
Song Xue
Hao Cai
Congwei Jia
Daobin Zhou
Wei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1365975

2,386 views
2 citations

Original Research

Published on 09 Feb 2024

MGMT unmethylation and high levels of CD47 and TIGIT indicate a poor prognosis in adult diffuse gliomas

in Cancer Immunity and Immunotherapy

Lingbo Ma
Yi Shi
Chang Li
Bin Deng
Jinfang Jiang
Yuwen Cao
Lianghai Wang
Hongyan Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1323307

2,660 views
4 citations

Mini Review

Published on 09 Feb 2024

CAR-NK cells for cancer immunotherapy: recent advances and future directions

in Cancer Immunity and Immunotherapy

Tianye Li
Mengke Niu
Weijiang Zhang
Shuang Qin
Jianwei Zhou
Ming Yi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1361194

15,875 views
32 citations

Case Report

Published on 09 Feb 2024

Case report: A case of rare metastasis of gastric cancer to the axillary lymph node metastasis treated with combination immunotherapy

in Cancer Immunity and Immunotherapy

Jin Wang
Yu Cheng
Yulin Wang
Hengxin Liu
Shuang Wu
Guangwei Tian
Jinglei Qu
Xiujuan Qu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1331506

2,692 views
1 citation

Correction

Published on 08 Feb 2024

Corrigendum: Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells

in Cancer Immunity and Immunotherapy

Zhenyu Wei
Jiayu Xu
Chengkui Zhao
Min Zhang
Nan Xu
Liqing Kang
Xiaoyan Lou
Lei Yu
Weixing Feng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1379325

1,323 views

Systematic Review

Published on 08 Feb 2024

Efficacy and toxicity of immune checkpoint inhibitors combination therapy for advanced renal cell carcinoma: a systematic review and network meta-analysis

in Cancer Immunity and Immunotherapy

Xiangyu Chen
Zhunan Xu
Changgui Wu
Lijun Xie
Pengyu Wang
Xiaoqiang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1255577

5,051 views
11 citations

Original Research

Published on 08 Feb 2024

Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8+ T lymphocytes infiltration

in Cancer Immunity and Immunotherapy

Jing Luo
Xiuhuan Shi
Yumeng Liu
Jian Wang
Hao Wang
Xuena Yang
Qian Sun
Zhenzhen Hui
Feng Wei
Xiubao Ren

Frontiers in Immunology

doi 10.3389/fimmu.2024.1302761

2,949 views
3 citations

Original Research

Published on 08 Feb 2024

Single-cell and Bulk RNA-Seq reveal angiogenic heterogeneity and microenvironmental features to evaluate prognosis and therapeutic response in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Lijuan Tang
Zhike Chen
Jian Yang
Qifan Li
Sichu Wang
Taoming Mo
Weibiao Zeng
Hao Ding
Shu Pan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1352893

5,019 views
3 citations

Original Research

Published on 08 Feb 2024

CD34+DNAM-1brightCXCR4+ haemopoietic precursors circulate after chemotherapy, seed lung tissue and generate functional innate-like T cells and NK cells

in Cancer Immunity and Immunotherapy

Carola Perrone
Federica Bozzano
Maria Giovanna Dal Bello
Genny Del Zotto
Francesca Antonini
Enrico Munari
Enrico Maggi
Francesca Moretta
Alireza Hajabbas Farshchi
Gianluca Pariscenti

Frontiers in Immunology

doi 10.3389/fimmu.2024.1332781

3,843 views
5 citations

Review

Published on 08 Feb 2024

Targeting MYC at the intersection between cancer metabolism and oncoimmunology

in Cancer Immunity and Immunotherapy

Simran Venkatraman
Brinda Balasubramanian
Chanitra Thuwajit
Jaroslaw Meller
Rutaiwan Tohtong
Somchai Chutipongtanate

Frontiers in Immunology

doi 10.3389/fimmu.2024.1324045

7,206 views
19 citations

Original Research

Published on 08 Feb 2024

Bibliometric analysis of evolutionary trajectory and prospective directions of LAG-3 in cancer

in Cancer Immunity and Immunotherapy

Jin Wang
Siying Wang
Yuting Zhang
Wei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1329775

5,748 views
2 citations

Review

Published on 08 Feb 2024

The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy

in Cancer Immunity and Immunotherapy

Aleksei A. Stepanenko
Anastasiia O. Sosnovtseva
Marat P. Valikhov
Anastasia A. Chernysheva
Olga V. Abramova
Victor A. Naumenko
Vladimir P. Chekhonin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1326757

7,529 views
9 citations